Taken together, these results showed that MNP-HC block HER2-mediated intracellular signaling and interfere with HER2-driven cancer cell proliferation, thus triggering a direct and potent antitumor efficacy in HER2+ breast cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.